258 related articles for article (PubMed ID: 25347437)
21. Actinic keratosis: review of the literature and new patents.
Cantisani C; De Gado F; Ulrich M; Bottoni U; Iacobellis F; Richetta AG; Calvieri S
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):168-75. PubMed ID: 23470197
[TBL] [Abstract][Full Text] [Related]
22. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
23. Core Outcome Set for Actinic Keratosis Clinical Trials.
Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
[TBL] [Abstract][Full Text] [Related]
24. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
25. Morphologic grading and treatment of facial actinic keratosis.
Zalaudek I; Piana S; Moscarella E; Longo C; Zendri E; Castagnetti F; Pellacani G; Lallas A; Argenziano G
Clin Dermatol; 2014; 32(1):80-7. PubMed ID: 24314380
[TBL] [Abstract][Full Text] [Related]
26. The importance of patient-centred care to overcome barriers in the management of actinic keratosis.
Cerio R
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():17-20. PubMed ID: 28263022
[TBL] [Abstract][Full Text] [Related]
27. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
Ulrich M; Pellacani G; Ferrandiz C; Lear JT
Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
[TBL] [Abstract][Full Text] [Related]
28. European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
Kandolf L; Peris K; Malvehy J; Mosterd K; Heppt MV; Fargnoli MC; Berking C; Arenberger P; Bylaite-Bučinskiene M; Del Marmol V; Dirschka T; Dreno B; Forsea AM; Harwood CA; Hauschild A; Heerfordt IM; Kauffman R; Kelleners-Smeets N; Lallas A; Lebbe C; Leiter U; Longo C; Mijušković Ž; Pellacani G; Puig S; Saiag P; Šitum M; Stockfleth E; Salavastru C; Stratigos A; Zalaudek I; Garbe C;
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1024-1047. PubMed ID: 38451047
[TBL] [Abstract][Full Text] [Related]
29. Actinic keratoses contiguous with squamous cell carcinomas are mostly non-hyperkeratotic and with severe dysplasia.
Heerfordt IM; Poulsen T; Wulf HC
J Clin Pathol; 2022 Aug; 75(8):560-563. PubMed ID: 33863749
[TBL] [Abstract][Full Text] [Related]
30. The depth of follicular extension in actinic keratosis correlates with the depth of invasion in squamous cell carcinoma: implication for clinical treatment.
Fernández-Figueras MT; Saenz-Sardà X; Vargas P; Thompson CT; Carrato C; Puig L; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1657-1661. PubMed ID: 29489051
[TBL] [Abstract][Full Text] [Related]
31. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects.
Reinehr CPH; Bakos RM
An Bras Dermatol; 2019; 94(6):637-657. PubMed ID: 31789244
[TBL] [Abstract][Full Text] [Related]
32. Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.
Berman B; Ablon GR; Bhatia ND; Ceilley RI; Goldberg DJ; Nestor MS; Weinkle SH
J Drugs Dermatol; 2017 Mar; 16(3):260-264. PubMed ID: 28301622
[TBL] [Abstract][Full Text] [Related]
33. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited.
Fernandez Figueras MT
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():5-7. PubMed ID: 28263020
[TBL] [Abstract][Full Text] [Related]
34. Actinic keratosis modelling in mice: A translational study.
Pillon A; Gomes B; Vandenberghe I; Cartron V; Cèbe P; Blanchet JC; Sibaud V; Guilbaud N; Audoly L; Lamant L; Kruczynski A
PLoS One; 2017; 12(6):e0179991. PubMed ID: 28662116
[TBL] [Abstract][Full Text] [Related]
35. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
36. [A plethora of choices: treating actinic keratoses].
Mühlstädt M; Tzika E; Boehncke WH
Rev Med Suisse; 2020 Apr; 16(688):646-650. PubMed ID: 32239839
[TBL] [Abstract][Full Text] [Related]
37. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
38. The importance of treating the field in actinic keratosis.
Stockfleth E
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
[TBL] [Abstract][Full Text] [Related]
39. [Actinic keratosis and squamous cell carcinoma of the elderly].
Colboc H; Meaume S
Rev Prat; 2017 Dec; 67(10):1084-1088. PubMed ID: 30512606
[TBL] [Abstract][Full Text] [Related]
40. New and current preventive treatment options in actinic keratosis.
Arenberger P; Arenbergerova M
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
